Confident Investing Starts With TipRanks Premium

Go Ultimate 55% OFF

Excellergy: Valuation, Funding & Investors

10 E Allen St Winooski, Vermont 05404, UShttps://www.excelergy.com/Therapeutics

Excellergy is a biotechnology company focused on developing a pioneering portfolio of trifunctional effector cell response inhibitors (ECRIs) to address severe allergic diseases. By utilizing clinically validated Immunoglobulin E (IgE) biology and innovative ECRI pharmacology, Excellergy aims to surpass traditional anti-IgE therapies by directly targeting the source of allergic signaling—IgE bound to effector cells. Headquartered in Palo Alto, California, the company is committed to advancing the standard of care in allergy treatment and improving patient quality of life.

Leadership & Board

Current Number of Employees: 26
Current LinkedIn Followers: 481

Latest Estimated Valuation

Total Amount Raised: $70M
Total Funding Rounds: 1
Latest Funding Amount: $70M
Latest Funding Round: Series A

Employee Trend

Excellergy had 26 employees as of October 26, 2026. The number of employees increased by 0 (0.00%) week-over-week.

26Latest Employee Count

0(0.00%)Week-Over-Week Change

Social Trend

Excellergy had 481 followers as of October 26, 2026. The number of followers increased by 0 (0.00%) week-over-week.

481Latest Followers Count

0(0.00%)Week-Over-Week Change

Funding Round

Funding Date	Funding Round	Amount Raised	Post-Money Valuation
Oct 13, 2025	Series A	$70.00M	―

Investors

Investor Name	Funding Round
Samsara BioCapital	Series A
Red Tree Venture Capital	Series A
Decheng Capital	Series A

Similar Companies

A snapshot of private companies similar to Excellergy, helping you discover and navigate related company profiles.

Tempero Bio Inc

Elevara Medicines

Related News and Analysis

Novartis to Acquire Excellergy in Allergy Drug Deal Worth Up to $2 Billion

Novartis to Acquire Excellergy in Allergy Drug Deal Worth Up to $2 Billion

New updates have been reported about Excellergy. Excellergy will be acquired by Novartis in a transaction valued at up to $2 billion in upfront and milestone payments, positioning the Palo

7M ago

Excellergy Advances First-in-Class Allergy Drug Exl-111 Into Phase 1, Backed by Strong Preclinical Data

Excellergy Advances First-in-Class Allergy Drug Exl-111 Into Phase 1, Backed by Strong Preclinical Data

New updates have been reported about Excellergy. Excellergy has released new preclinical data on its lead candidate Exl-111 and confirmed that the first subjects have been dosed in the Phase

8M ago

Spargo Space Promotes Space Autonomy Talent Development in Orlando

Spargo Space Promotes Space Autonomy Talent Development in Orlando

According to a recent LinkedIn post from Spargo Space, the company is organizing the Orlando Space Autonomy Series, a free, hands-on workshop program in Central Florida. The post indicates the

10h ago

Finary Uses Customer Banking Stories to Strengthen Brand Positioning

According to a recent LinkedIn post from Finary, the French fintech is leveraging Halloween-themed content to engage its community around negative banking experiences. The post describes a campaign in which

10h ago

AI-Driven Hospital Billing Positioned as Revenue and Efficiency Opportunity

AI-Driven Hospital Billing Positioned as Revenue and Efficiency Opportunity

According to a recent LinkedIn post from Revena, the company highlights persistent inefficiencies in hospital billing processes that can lead to significant revenue leakage. The post emphasizes that in high-volume

10h ago

Intellijoint Surgical Targets Sales Channel Engagement at AAHKS 2026

Intellijoint Surgical Targets Sales Channel Engagement at AAHKS 2026

A LinkedIn post from Intellijoint Surgical Inc highlights an event planned for independent sales representatives attending the AAHKS 2026 meeting. The company is inviting these reps to an evening gathering

10h ago

Eight Sleep Expands Personalized Sleep Offering With Menopause-Focused Features

Eight Sleep Expands Personalized Sleep Offering With Menopause-Focused Features

A LinkedIn post from Eight Sleep highlights a new Menopause Mode feature within the company’s sleep technology app. The post describes how users can switch from Standard to Menopause Mode,

10h ago

Simpro Targets Margin Optimization Opportunities in Trade Businesses

Simpro Targets Margin Optimization Opportunities in Trade Businesses

According to a recent LinkedIn post from Simpro Software, Chairman and CEO Fred Voccola highlights a key challenge for trade and field-service businesses: persistently low, single-digit margins despite strong technical

10h ago

MotherDuck Highlights Guides Feature for Consistent Metric Definitions

MotherDuck Highlights Guides Feature for Consistent Metric Definitions

According to a recent LinkedIn post from MotherDuck, the company is emphasizing a feature called Guides aimed at improving how organizations define and manage analytics metrics across agent sessions. The

10h ago

Simpro Highlights AI-Driven Efficiency for Trade and Field Service Contractors

Simpro Highlights AI-Driven Efficiency for Trade and Field Service Contractors

According to a recent LinkedIn post from Simpro Software, the company is emphasizing the role of artificial intelligence in reducing non-billable administrative work for trade contractors and field service teams.

10h ago